Piramal Pharma reports over 4-fold jump in Q2 consolidated net profit

24 Oct 2024 Evaluate

Piramal Pharma has reported results for second quarter ended September 30, 2024 (Q2FY25).

The company has reported over 2-fold jump in its net profit at Rs 210.06 crore for the quarter ended September 30, 2024 as compared to Rs 77.16 crore for the same quarter in the previous year. Total income of the company increased by 28.38% at Rs 1,390.77 crore for Q2FY25 as compared to Rs 1,083.32 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported over 4-fold jump in net profit at Rs 22.59 crore for Q2FY25 as compared to Rs 5.02 crore for the same quarter in the previous year. Total income of the company increased by 17.46% at Rs 2302.86 crore for Q2FY25 as compared to Rs 1960.57 crore for the corresponding quarter previous year.

Piramal Pharma Share Price

252.60 -9.00 (-3.44%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.